BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Sep 13, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Qvar beclomethasone dipropionate inflammation data

Qvar is approved for the maintenance treatment of asthma as prophylactic therapy in patients ages 5 and older, and to treat asthma patients who require systemic corticosteroid administration. GlaxoSmithKline plc (LSE:GSK; NYSE:GSK, London, U.K.) markets Flovent

Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA), Petah Tikva, Israel
Product: ...

Read the full 225 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >